col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


314 Results       Page 1

 [1] 
American Society for Microbiology: mBio
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―29 Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection Youliang Rao, Chao Qin, Bianca Espinosa, Ting-Yu Wang, Shu Feng, Ali Can Savas, et al. (+5)
2 [GO] 2025―Apr―29 Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3 Yanping Hu, Jing Zou, Michael D. Nguyen, Hope C. Chang, Jason Yeung, Haiping Hao, et al. (+4)
3 [GO] 2025―Apr―24 A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model Anna Pons-Grífols, Ferran Tarrés-Freixas, Mònica Pérez, Eva Riveira-Muñoz, Dàlia Raïch-Regué, Daniel Perez-Zsolt, et al. (+15)
4 [GO] 2025―Apr―21 Infectivity and structure of SARS-CoV-2 after hydrogen peroxide treatment Saba R. Aliyari, Guodong Xie, Xian Xia, Lulan Wang, Z. Hong Zhou, Genhong Cheng, Suresh Mahalingam
5 [GO] 2025―Apr―09 Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50 Sarah N. Zvornicanin, Ala M. Shaqra, Julia Flynn, Heidi Carias Martinez, Weiping Jia, Stephanie Moquin, et al. (+5)
6 [GO] 2025―Apr―01 RAB5 is a host dependency factor for the generation of SARS-CoV-2 replication organelles Yuexuan Chen, Susanne Klute, Konstantin Maria Johannes Sparrer, Ruth Serra-Moreno, Stephen P. Goff, Paul Ahlquist
7 [GO] 2025―Mar―05 XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, Anass Abbad, Temima Yellin, Jordan Ehrenhaus, et al. (+23)
8 [GO] 2025―Feb―25 SARS-CoV-2 infectivity can be modulated through bacterial grooming of the glycocalyx Cameron Martino, Benjamin P. Kellman, Daniel R. Sandoval, Thomas Mandel Clausen, Robert Cooper, Alhosna Benjdia, et al. (+60)
9 [GO] 2025―Jan―29 Erratum for Guo et al., “Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis” Mingquan Guo, Guojun Wu, Yun Tan, Yan Li, Xin Jin, Weiqiang Qi, et al. (+4)
10 [GO] 2025―Jan―29 Cells that survive acute SARS-CoV-2 infection contribute to inflammation and lung regeneration in mice Ruangang Pan, David K. Meyerholz, Stanley Perlman, Stephen Turner
11 [GO] 2024―Dec―31 Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us? Iván Sanz-Muñoz, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Corina S. Concha-Santos, Marta Hernández, Silvia Rojo-Rello, et al. (+6)
12 [GO] 2024―Dec―23 Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences Liwei Li, Jinxia Chen, Zhengda Cao, Ziqiang Guo, Jiachen Liu, Yanjun Zhou, et al. (+4)
13 [GO] 2024―Dec―04 Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals Najwa D. Aljehani, Levi Tamming, Muhammad Yasir Khan, Rwaa H. Abdulal, Mohamed A. Alfaleh, Aishah Ghazwani, et al. (+26)
14 [GO] 2024―Nov―29 Coatomer complex I is required for the transport of SARS-CoV-2 progeny virions from the endoplasmic reticulum-Golgi intermediate compartment Ai Hirabayashi, Yukiko Muramoto, Toru Takenaga, Yugo Tsunoda, Mayumi Wakazaki, Mayuko Sato, et al. (+9)
15 [GO] 2024―Nov―22 Development of a metabolome-based respiratory infection prognostic during COVID-19 arrival John I. Robinson, Laura R. Marks, Andrew L. Hinton, Jane A. O'Halloran, Charles W. Goss, Peter J. Mucha, et al. (+2)
16 [GO] 2024―Nov―18 Hyaluronan in COVID-19: a matrix for understanding lung disease Rebecca J. Dodd, Judith E. Allen, Anthony J. Day, Sabra Klein
17 [GO] 2024―Oct―31 Performance of rapid antigen tests to detect SARS-CoV-2 variant diversity and correlation with viral culture positivity: implication for diagnostic development and future public health strategies Heather Goux, Jennetta Green, Andrew Wilson, Shanmuga Sozhamannan, Stephanie A. Richard, Rhonda Colombo, et al. (+14)
18 [GO] 2024―Oct―30 C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic Peter Simmonds, Dimitrios Paraskevis
19 [GO] 2024―Oct―23 Biochemical analysis of packing and assembling heptad repeat motifs in the coronavirus spike protein trimer Jun Kobayashi, Kazuhiko Kanou, Hiyori Okura, Tahmina MST Akter, Shuetsu Fukushi, Shutoku Matsuyama, et al. (+2)
20 [GO] 2024―Sep―30 SARS-CoV-2 ORF3a induces COVID-19-associated kidney injury through HMGB1-mediated cytokine production Chenyu Zhang, Volodymyr Gerzanich, Ruth Cruz-Cosme, Jiantao Zhang, Orest Tsymbalyuk, Cigdem Tosun, et al. (+11)
21 [GO] 2024―Sep―20 SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study Urban Hellman, Ebba Rosendal, Joakim Lehrstrand, Johan Henriksson, Tove Björsell, Alfred Wennemo, et al. (+18)
22 [GO] 2024―Sep―16 Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants Hisano Yajima, Tomo Nomai, Kaho Okumura, Katsumi Maenaka, Jumpei Ito, Takao Hashiguchi, et al. (+95)
23 [GO] 2024―Sep―09 Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations Junxiang Wang, Kaiyi Li, Yuan Wang, Zhengfang Lin, Weidong Li, Jinpeng Cao, et al. (+9)
24 [GO] 2024―Sep―09 Vaccine-induced NA immunity decreases viral shedding, but does not disrupt chains of airborne transmission for the 2009 pandemic H1N1 virus in ferrets K. M. Septer, T. A. Heinly, D. G. Sim, D. R. Patel, A. E. Roder, W. Wang, et al. (+6)
25 [GO] 2024―Sep―06 Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2 Leon L. Hsieh, Monika Looney, Alexis Figueroa, Guido Massaccesi, Georgia Stavrakis, Eduardo U. Anaya, et al. (+8)
26 [GO] 2024―Aug―29 Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis Michael W. Russell, Mogens Kilian, Jiri Mestecky, Nancy E. Freitag
27 [GO] 2024―Aug―22 Interferon-stimulated genes and their antiviral activity against SARS-CoV-2 Ana Maria Ortega-Prieto, Jose M. Jimenez-Guardeño, Vinayaka R. Prasad
28 [GO] 2024―Aug―14 CD81 fusion alters SARS-CoV-2 Spike trafficking Allaura S. Cone, Yijun Zhou, Ryan P. McNamara, Anthony. B. Eason, Gabriel F. Arias, Justin T. Landis, et al. (+7)
29 [GO] 2024―Aug―08 SARS-CoV-2 spike fusion peptide trans interaction with phosphatidylserine lipid triggers membrane fusion for viral entry Puspangana Singh, Purba Pahari, Srija Mukherjee, Sharmistha Karmakar, Markus Hoffmann, Taraknath Mandal, et al. (+2)
30 [GO] 2024―Aug―06 A decavalent composite mRNA vaccine against both influenza and COVID-19 Yang Wang, Qinhai Ma, Man Li, Qianyi Mai, Lin Ma, Hong Zhang, et al. (+12)
31 [GO] 2024―Jul―22 SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus Ashira Lubkin, Lucie Bernard-Raichon, Ashley L. DuMont, Ana Mayela Valero Jimenez, Gregory G. Putzel, Juan Gago, et al. (+32)
32 [GO] 2024―Jul―22 Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines Gang Zhong, Jinrong Li, Huiqing Wang, Sabra Klein
33 [GO] 2024―Jul―02 The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2 Fei Yu, Xiaoqing Liu, Hailan Ou, Xinyu Li, Ruxin Liu, Xi Lv, et al. (+16)
34 [GO] 2024―Jun―20 IL-9 plays a critical role in helminth-induced protection against COVID-19-related cytokine storms ChunXiao Xiang, Gang Zhong, Huiqing Wang, Chunfu Zheng
35 [GO] 2024―Jun―18 Estimating the productivity cost of administrative duties and work-related engagements from submission trends during COVID-19 pandemic lockdown Arturo Casadevall, Lorraine F. Clark
36 [GO] 2024―May―23 Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks Evan M. Bloch, David J. Sullivan, Arturo Casadevall, Shmuel Shoham, Aaron A. R. Tobian, Kelly Gebo, Louis M. Weiss
37 [GO] 2024―May―21 Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo Daniel L. Kober, Marley C. Caballero Van Dyke, Jennifer L. Eitson, Ian N. Boys, Matthey B. McDougal, Daniel M. Rosenbaum, et al. (+2)
38 [GO] 2024―May―10 Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way Zengguo Cao, Jiaqi Wang, Xiaolei Liu, Yang Liu, Fangxu Li, Mingyuan Liu, et al. (+3)
39 [GO] 2024―Apr―11 Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19 Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, et al. (+19)
40 [GO] 2024―Apr―09 Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion Pei Li, Yajie Liu, Julia N. Faraone, Cheng Chih Hsu, Michelle Chamblee, Yi-Min Zheng, et al. (+11)
41 [GO] 2024―Apr―09 The potentiality of bacteria to drive SARS-CoV-2 mutation Xiangyu Zhang, Shun Li, Mengzhou Xue, Chunfu Zheng
42 [GO] 2024―Apr―08 Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, et al. (+4)
43 [GO] 2024―Mar―26 The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations Birong Cao, Xiaoxi Wang, Wanchao Yin, Zhaobing Gao, Bingqing Xia, Chunfu Zheng
44 [GO] 2024―Mar―21 Erratum for Karaba et al., “Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment” Andrew H. Karaba, Trevor S. Johnston, Evan Beck, Oliver Laeyendecker, Andrea L. Cox, Sabra L. Klein, David J. Sullivan
45 [GO] 2024―Mar―19 ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients Yufeng Song, Regan Myers, Frances Mehl, Lila Murphy, Bailey Brooks, Jeffrey M. Wilson, et al. (+4)
46 [GO] 2024―Mar―13 Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating Nikhila S. Tanneti, Anant K. Patel, Li Hui Tan, Andrew D. Marques, Ranawaka A. P. M. Perera, Scott Sherrill-Mix, et al. (+10)
47 [GO] 2024―Mar―08 SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, et al. (+8)
48 [GO] 2024―Feb―27 Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling Wai-Yin Lui, Chon Phin Ong, Pak-Hin Hinson Cheung, Zi-Wei Ye, Chi-Ping Chan, Kelvin Kai-Wang To, et al. (+3)
49 [GO] 2024―Feb―27 Temperature impacts SARS-CoV-2 spike fusogenicity and evolution Jérémy Dufloo, Rafael Sanjuán, Vaughn S. Cooper, Christopher B. Brooke
50 [GO] 2024―Feb―26 Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses Daniel J. Salamango, Rino Rappuoli
51 [GO] 2024―Feb―16 SARS-CoV-2 evolution during prolonged infection in immunocompromised patients Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, Ashley Sobel Leonard, Emma J. Cook, John K. Everett, et al. (+6)
52 [GO] 2024―Feb―13 Two complete 1918 influenza A/H1N1 pandemic virus genomes characterized by next-generation sequencing using RNA isolated from formalin-fixed, paraffin-embedded autopsy lung tissue samples along with evidence of secondary bacterial co-infection Yongli Xiao, Zong-Mei Sheng, Stephanie L. Williams, Jeffery K. Taubenberger, John A. Lednicky
53 [GO] 2024―Feb―13 Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels Qiru Zeng, Avan Antia, Luis Alberto Casorla-Perez, Maritza Puray-Chavez, Sebla B. Kutluay, Matthew A. Ciorba, et al. (+2)
54 [GO] 2024―Feb―02 NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, et al. (+14)
55 [GO] 2024―Jan―26 The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8 Lujie Fan, Yuzheng Zhou, Xiafei Wei, Wei Feng, Huimin Guo, Yunfei Li, et al. (+9)
56 [GO] 2024―Jan―25 Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection Irene A. Abela, Magdalena Schwarzmüller, Agne Ulyte, Thomas Radtke, Sarah R. Haile, Priska Ammann, et al. (+20)
57 [GO] 2024―Jan―24 CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation Linran Zhang, Pengfei Hao, Xiang Chen, Shuai Lv, Wenying Gao, Chang Li, et al. (+3)
58 [GO] 2024―Jan―09 Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity Miguel Á. Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, Lianwen Zhang, Nandakumar Packiriswamy, Gagandeep Singh, et al. (+9)
59 [GO] 2024―Jan―09 SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity Fengwen Zhang, Fabian Schmidt, Frauke Muecksch, Zijun Wang, Anna Gazumyan, Michel C. Nussenzweig, et al. (+5)
60 [GO] 2023―Dec―21 Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment Pengfei Li, Yunjeong Kim, Chamandi S. Dampalla, Harry Nhat Nguyen, David K. Meyerholz, David K. Johnson, et al. (+6)
61 [GO] 2023―Dec―19 Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency Kaiyuan Shi, Linjie Li, Chunliang Luo, Zepeng Xu, Baihan Huang, Sufang Ma, et al. (+4)
62 [GO] 2023―Dec―11 Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation Jiantao Zhang, Ruth Cruz-Cosme, Chenyu Zhang, Dongxiao Liu, Qiyi Tang, Richard Y. Zhao, Diane E. Griffin
63 [GO] 2023―Dec―11 The American Academy of Microbiology discusses gain-of-function research of concern (GOFROC) and enhanced potential pandemic pathogens (ePPP) Arturo Casadevall, Michael J. Imperiale, Nguyen K. Nguyen, Vanessa Sperandio
64 [GO] 2023―Dec―06 An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody Kristina E. Atanasoff, Luca Brambilla, Daniel C. Adelsberg, Shreyas Kowdle, Christian S. Stevens, Stefan Slamanig, et al. (+11)
65 [GO] 2023―Dec―04 The glycoprotein 5 of porcine reproductive and respiratory syndrome virus stimulates mitochondrial ROS to facilitate viral replication Shuang Zhang, Lei Zeng, Bing-Qian Su, Guo-Yu Yang, Jiang Wang, Sheng-Li Ming, et al. (+2)
66 [GO] 2023―Dec―01 Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection Disha Bhavsar, Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, Juan Manuel Carreno, et al. (+23)
67 [GO] 2023―Nov―29 Diversity of short linear interaction motifs in SARS-CoV-2 nucleocapsid protein Peter Schuck, Huaying Zhao, Nihal Altan-Bonnet
68 [GO] 2023―Nov―10 Correction for Castaño-Rodriguez et al., “Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis” Carlos Castaño-Rodríguez, Jose M. Honrubia, Javier Gutierrez-Álvarez, Marta L. DeDiego, Jose L. Nieto-Torres, Jose M. Jimenez-Guardeño, et al. (+9)
69 [GO] 2023―Nov―08 Seasonality of endemic COVID-19 Jeffrey P. Townsend, Hayley B. Hassler, April D. Lamb, Pratha Sah, Aia Alvarez Nishio, Cameron Nguyen, et al. (+4)
70 [GO] 2023―Nov―08 Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma Armando M. Perichon, Andrea Acosta, Liliana Di Tulio, Maria José Munuce, Stella Pezzotto, Oscar Bottasso, et al. (+2)
71 [GO] 2023―Oct―26 Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice Lok-Yin Roy Wong, Abby Odle, Emma Luhmann, Douglas C. Wu, Yiquan Wang, Qi Wen Teo, et al. (+10)
72 [GO] 2023―Oct―26 An account of American Academy of Microbiology reforms and pandemic operations Arturo Casadevall, Peggy A. Cotter, Lynn Enquist, Timothy J. Donohue, Stefano Bertuzzi, Nguyen K. Nguyen
73 [GO] 2023―Oct―13 Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers Muhammad S. Khan, Eun Kim, Quentin Le Hingrat, Adam Kleinman, Alessandro Ferrari, Jose C. Sammartino, et al. (+10)
74 [GO] 2023―Sep―08 Predicting COVID-19 prognosis in hospitalized patients based on early status David Natanov, Byron Avihai, Erin McDonnell, Eileen Lee, Brennan Cook, Nicole Altomare, et al. (+9)
75 [GO] 2023―Aug―25 SARS-CoV-2 ORF8 accessory protein is a virulence factor M. Bello-Perez, J. Hurtado-Tamayo, A. Z. Mykytyn, M. M. Lamers, R. Requena-Platek, D. Schipper, et al. (+8)
76 [GO] 2023―Aug―15 Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses Jeremy Ardanuy, Robert Johnson, Carly Dillen, Louis Taylor, Holly Hammond, Stuart Weston, et al. (+2)
77 [GO] 2023―Aug―03 Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data Yinong Young-Xu, Lauren Epstein, Vincent C. Marconi, Victoria Davey, Caroline Korves, Gabrielle Zwain, et al. (+5)
78 [GO] 2023―Aug―03 Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern Ryan P. McNamara, Jenny S. Maron, Julie Boucau, Vicky Roy, Nicholas E. Webb, Harry L. Bertera, et al. (+16)
79 [GO] 2023―Jul―28 SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein Bonnie H. Yeung-Luk, Gitanjali A. Narayanan, Baishakhi Ghosh, Ara Wally, Esther Lee, Michelle Mokaya, et al. (+13)
80 [GO] 2023―Jul―21 SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein Shuchen Feng, Amornrat O'Brien, Da-Yuan Chen, Mohsan Saeed, Susan C. Baker, J. S. Malik Peiris
81 [GO] 2023―Jul―13 SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense Xiaohui Ju, Ziqiao Wang, Pengcheng Wang, Wenlin Ren, Yanying Yu, Yin Yu, et al. (+10)
82 [GO] 2023―Jul―12 Bidirectional interplay between SARS-CoV-2 and autophagy Hao Zhou, Zhiqiang Hu, Sergio Castro-Gonzalez, Vinayaka R. Prasad
83 [GO] 2023―Jun―30 Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data A. E. Roder, K. E. E. Johnson, M. Knoll, M. Khalfan, B. Wang, S. Schultz-Cherry, et al. (+16)
84 [GO] 2023―Jun―29 Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4) Ramanjit Kaur, Takuya Tada, Nathaniel Roy Landau, Ronald Swanstrom
85 [GO] 2023―Jun―29 Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages Enya Qing, Tom Gallagher, Kanta Subbarao
86 [GO] 2023―Jun―28 mLST8 is essential for coronavirus replication and regulates its replication through the mTORC1 pathway Yanan Fu, Zhen Fu, Zhelin Su, Lisha Li, Yilin Yang, Yubei Tan, et al. (+7)
87 [GO] 2023―Jun―28 SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection Minghua Li, Kasirajan Ayyanathan, Mark Dittmar, Jesse Miller, Iulia Tapescu, Jae Seung Lee, et al. (+7)
88 [GO] 2023―Jun―23 SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication Christina A. Higgins, Benjamin E. Nilsson-Payant, Boris Bonaventure, Andrew P. Kurland, Chengjin Ye, Tomer M. Yaron, et al. (+11)
89 [GO] 2023―Jun―20 A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance Samantha L. Grimes, Young J. Choi, Anoosha Banerjee, Gabriel Small, Jordan Anderson-Daniels, Jennifer Gribble, et al. (+8)
90 [GO] 2023―Jun―12 The unfolded protein response components IRE1α and XBP1 promote human coronavirus infection Jessica M. Oda, Andreas B. den Hartigh, Shoen M. Jackson, Ana R. Tronco, Susan L. Fink, Sara Cherry, Matthew B. Frieman
91 [GO] 2023―Jun―09 Mild SARS-CoV-2 infection results in long-lasting microbiota instability Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, Maria McCavitt-Malvido, Renuka G. Kumar, Victoria Wong Murray, et al. (+11)
92 [GO] 2023―Jun―05 SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion Binbin Xi, Xi Zeng, Zixi Chen, Jiong Zeng, Lizhen Huang, Hongli Du, Chunfu Zheng
93 [GO] 2023―Apr―19 Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection Terry Zhou, Nora J. Gilliam, Sizhen Li, Simone Spandau, Raven M. Osborn, Sarah Connor, et al. (+9)
94 [GO] 2023―Apr―19 Rational Discourse on Virology and Pandemics David Bahry
95 [GO] 2023―Apr―13 Deficient Phagocytosis in Circulating Monocytes from Patients with COVID-19-Associated Mucormycosis Bishnu Prasad Sinha, Priyanka Mehta, Md Asmaul Hoque, Purbita Bandopadhyay, Ayandip Nandi, Ipsita Saha, et al. (+8)
96 [GO] 2023―Apr―11 COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma David Sullivan, Arturo Casadevall
97 [GO] 2023―Apr―10 SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters Jessica Plunkard, Kathleen Mulka, Ruifeng Zhou, Patrick Tarwater, William Zhong, Margaret Lowman, et al. (+5)
98 [GO] 2023―Apr―03 Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant Wenlin Ren, Yu Zhang, Juhong Rao, Ziyi Wang, Jun Lan, Kunpeng Liu, et al. (+9)
99 [GO] 2023―Mar―28 BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial Juana Claus, Thijs ten Doesschate, Cheyenne Gumbs, Cornelis H. van Werkhoven, Thomas W. van der Vaart, Axel B. Janssen, et al. (+36)
100 [GO] 2023―Mar―10 A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses James C. Alwine, Arturo Casadevall, Lynn W. Enquist, Felicia D. Goodrum, Michael J. Imperiale
101 [GO] 2023―Mar―09 SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City Yang Wang, Julianna Lenoch, Dennis Kohler, Thomas J. DeLiberto, Cynthia Y. Tang, Tao Li, et al. (+7)
102 [GO] 2023―Feb―28 SARS-CoV-2 SUD2 and Nsp5 Conspire to Boost Apoptosis of Respiratory Epithelial Cells via an Augmented Interaction with the G-Quadruplex of BclII Ying Li, Quanwei Yu, Ridong Huang, Hai Chen, Hequan Ren, Lingling Ma, et al. (+3)
103 [GO] 2023―Feb―23 Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname R. Bihariesingh-Sanchit, R. Bansie, N. Ramdhani, R. Mangroo, D. Bustamente, E. Diaz, et al. (+8)
104 [GO] 2023―Feb―14 Strategy To Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin Yong Yang, Xu-Rui Shen, Yu-Lan Zhang, Ren-di Jiang, Xi Wang, Zhen-Qiong Guan, et al. (+12)
105 [GO] 2023―Feb―14 High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020 Shuting Zhang, Peijun Ma, Marek Orzechowski, Allison Lemmer, Kara Rzasa, Josephine Bagnall, et al. (+25)
106 [GO] 2023―Feb―14 Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants Justin T. Landis, Razia Moorad, Linda J. Pluta, Carolina Caro-Vegas, Ryan P. McNamara, Anthony B. Eason, et al. (+9)
107 [GO] 2023―Feb―06 Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis Mingquan Guo, Guojun Wu, Yun Tan, Yan Li, Xin Jin, Weiqiang Qi, et al. (+5)
108 [GO] 2023―Feb―02 Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2 Pratima Saini, Opeyemi S. Adeniji, Devivasha Bordoloi, Jennifer Kinslow, Jeff Martinson, Danielle M. Parent, et al. (+14)
109 [GO] 2023―Jan―18 Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity? Lisa Bauer, Debby van Riel
110 [GO] 2023―Jan―10 Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment Andrew H. Karaba, Trevor S. Johnston, Evan Beck, Oliver Laeyendecker, Andrea L. Cox, Sabra L. Klein, et al. (+61)
111 [GO] 2023―Jan―10 The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir Dirk Jochmans, Cheng Liu, Kim Donckers, Antitsa Stoycheva, Sandro Boland, Sarah K. Stevens, et al. (+20)
112 [GO] 2023―Jan―10 SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators Jose M. Honrubia, Javier Gutierrez-Álvarez, Alejandro Sanz-Bravo, Ezequiel González-Miranda, Diego Muñoz-Santos, Carlos Castaño-Rodriguez, et al. (+12)
113 [GO] 2023―Jan―09 Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA Matthew F. Smith, Steven C. Holland, Mihyun B. Lee, James C. Hu, Nghia C. Pham, Regan A. Sullins, et al. (+15)
114 [GO] 2022―Dec―05 Correction for Zhou et al., “Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections” Jing Zou, Xuping Xie, Mingru Liu, Pei-Yong Shi, Ping Ren
115 [GO] 2022―Nov―16 Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, et al. (+131)
116 [GO] 2022―Nov―03 Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2 Julia Eder, Marta Bermejo-Jambrina, Killian E. Vlaming, Tanja M. Kaptein, Viktoria Zaderer, E. Marleen Kemper, et al. (+6)
117 [GO] 2022―Oct―31 Commentary on “Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study” Michael J. Joyner, Nigel Paneth
118 [GO] 2022―Oct―31 Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons Weili Kong, Mauricio Montano, Michael J. Corley, Ekram Helmy, Hirofumi Kobayashi, Martin Kinisu, et al. (+8)
119 [GO] 2022―Oct―18 Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies Andrea T. Hooper, Selin Somersan-Karakaya, Shane E. McCarthy, Eleftherios Mylonakis, Shazia Ali, Jingning Mei, et al. (+9)
120 [GO] 2022―Oct―05 The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation Khurts Shilagardi, Eric D. Spear, Rachy Abraham, Diane E. Griffin, Susan Michaelis, Michael S. Diamond
121 [GO] 2022―Oct―03 Correction for Zhao et al., “Gasdermin D Inhibits Coronavirus Infection by Promoting the Noncanonical Secretion of Beta Interferon” Liyuan Zhao, Liang Li, Mei Xue, Xiang Liu, Chengfan Jiang, Wenzhe Wang, et al. (+3)
122 [GO] 2022―Sep―22 Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model Joanna A. Pulit-Penaloza, Jessica A. Belser, Xiangjie Sun, Claudia Pappas, Nicole Brock, Troy J. Kieran, et al. (+11)
123 [GO] 2022―Sep―22 Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, Jessica Keys, Heather Root, Heather I. Henderson, et al. (+16)
124 [GO] 2022―Sep―20 Building a Resilient Scientific Network for COVID-19 and Beyond N. Esther Babady, Rachel M. Burckhardt, Florian Krammer, Penny L. Moore, Lynn W. Enquist, Rino Rappuoli
125 [GO] 2022―Sep―20 SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells Long C. Nguyen, David M. Renner, Diane Silva, Dongbo Yang, Nicholas A. Parenti, Kaeri M. Medina, et al. (+20)
126 [GO] 2022―Aug―31 Correction for Merenstein et al., “Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome” Carter Merenstein, Guanxiang Liang, Samantha A. Whiteside, Ana G. Cobián-Güemes, Madeline S. Merlino, Louis J. Taylor, et al. (+15)
127 [GO] 2022―Aug―24 Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania Andrew D. Marques, Scott Sherrill-Mix, John K. Everett, Hriju Adhikari, Shantan Reddy, Julie C. Ellis, et al. (+11)
128 [GO] 2022―Aug―24 Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity Kathryn A. Bowman, Daniel Stein, Sally Shin, Kathie G. Ferbas, Nicole H. Tobin, Colin Mann, et al. (+7)
129 [GO] 2022―Aug―23 Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey Barun Mathema, Liang Chen, Pengfei Wang, Marcus H. Cunningham, Jose R. Mediavilla, Kar Fai Chow, et al. (+20)
130 [GO] 2022―Aug―23 SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants John Kubale, Charles Gleason, Juan Manuel Carreño, Komal Srivastava, Gagandeep Singh, Aubree Gordon, et al. (+32)
131 [GO] 2022―Aug―16 The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico Rodrigo García-López, Estibalitz Laresgoiti-Servitje, Roselyn Lemus-Martin, Alejandro Sanchez-Flores, Carlos Sanders-Velez, Jeremy Phillip Kamil, Vinayaka R. Prasad
132 [GO] 2022―Aug―08 Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants Man Chun Chiu, Cun Li, Xiaojuan Liu, Wenjun Song, Zhixin Wan, Yifei Yu, et al. (+8)
133 [GO] 2022―Aug―04 Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections Jing Zou, Xuping Xie, Mingru Liu, Pei-Yong Shi, Ping Ren, Sara Cherry
134 [GO] 2022―Aug―01 Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease Annelies Stevaert, Ria Van Berwaer, Cato Mestdagh, Julie Vandeput, Els Vanstreels, Valerie Raeymaekers, et al. (+3)
135 [GO] 2022―Jul―28 A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine Jingen Zhu, Swati Jain, Jian Sha, Himanshu Batra, Neeti Ananthaswamy, Paul B. Kilgore, et al. (+13)
136 [GO] 2022―Jul―20 Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation Hironori Nishitsuji, Satoko Iwahori, Mariko Ohmori, Kunitada Shimotohno, Takayuki Murata, Adriana Forero, Kellie Jurado
137 [GO] 2022―Jul―13 A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry Liangqin Tong, Lin Wang, Shumin Liao, Xiaoping Xiao, Jing Qu, Chunli Wu, et al. (+9)
138 [GO] 2022―Jul―13 Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid Jonathan T. Lee, Qingyi Yang, Alexey Gribenko, B. Scott Perrin, Yuao Zhu, Rhonda Cardin, et al. (+4)
139 [GO] 2022―Jun―28 The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia Chuangqi Wang, Yijia Li, Paulina Kaplonek, Matteo Gentili, Stephanie Fischinger, Kathryn A. Bowman, et al. (+11)
140 [GO] 2022―Jun―23 Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population Eva Bednarski, Perla M. Del Rio Estrada, Justin DaSilva, Celia Boukadida, Fengwen Zhang, Yara A. Luna-Villalobos, et al. (+19)
141 [GO] 2022―Jun―21 Microbiome Analysis for Wastewater Surveillance during COVID-19 Kyle D. Brumfield, Menu Leddy, Moiz Usmani, Joseph A. Cotruvo, Ching-Tzone Tien, Suzanne Dorsey, et al. (+13)
142 [GO] 2022―Jun―16 Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein Mizuki Yamamoto, Jin Gohda, Ayako Kobayashi, Keiko Tomita, Youko Hirayama, Naohiko Koshikawa, et al. (+6)
143 [GO] 2022―Jun―13 Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern Katharina S. Schmitz, Daryl Geers, Rory D. de Vries, T. Francesca Bovier, Anna Z. Mykytyn, Corine H. Geurts van Kessel, et al. (+5)
144 [GO] 2022―May―31 The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b Wenying Gao, Liuli Wang, Xiaohui Ju, Simin Zhao, Zhaolong Li, Manman Su, et al. (+6)
145 [GO] 2022―May―23 The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes Maritza Puray-Chavez, Nakyung Lee, Kasyap Tenneti, Yiqing Wang, Hung R. Vuong, Yating Liu, et al. (+10)
146 [GO] 2022―May―19 Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells Subhayan Sur, Robert Steele, T. Scott Isbell, Ranjit Ray, Ratna B. Ray, Andrea L. Cox, Diane E. Griffin
147 [GO] 2022―May―09 Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections Ebba Rosendal, Ionut Sebastian Mihai, Miriam Becker, Debojyoti Das, Lars Frängsmyr, B. David Persson, et al. (+10)
148 [GO] 2022―Apr―27 Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19 Wei Zhao, Weixin Chen, Juan Li, Meng Chen, Qin Li, Min Lv, et al. (+9)
149 [GO] 2022―Apr―26 Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, Jordan T. Becker, Sofia N. Moraes, Constance B. Anderson, et al. (+12)
150 [GO] 2022―Apr―25 Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy Markus Hoffmann, Anzhalika Sidarovich, Prerna Arora, Nadine Krüger, Inga Nehlmeier, Amy Kempf, et al. (+9)
151 [GO] 2022―Apr―25 Epidemiology and Genomic Characterization of Two Novel SARS-Related Coronaviruses in Horseshoe Bats from Guangdong, China Linmiao Li, Libiao Zhang, Jiabin Zhou, Xiangyang He, Yepin Yu, Ping Liu, et al. (+4)
152 [GO] 2022―Apr―25 Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain Clara G. Altomare, Daniel C. Adelsberg, Juan Manuel Carreno, Iden A. Sapse, Fatima Amanat, Ali H. Ellebedy, et al. (+4)
153 [GO] 2022―Apr―25 Porcine Reproductive and Respiratory Syndrome Virus Adapts Antiviral Innate Immunity via Manipulating MALT1 Han Gu, Suya Zheng, Guangwei Han, Haotian Yang, Zhuofan Deng, Zehui Liu, et al. (+2)
154 [GO] 2022―Apr―14 Erratum for Vanderheiden et al., “CCR2 Signaling Restricts SARS-CoV-2 Infection” Abigail Vanderheiden, Jeronay Thomas, Allison L. Soung, Meredith E. Davis-Gardner, Katharine Floyd, Fengzhi Jin, et al. (+12)
155 [GO] 2022―Apr―14 The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan Xiang Liu, Helen Mostafavi, Wern Hann Ng, Joseph R. Freitas, Nicholas J. C. King, Ali Zaid, et al. (+3)
156 [GO] 2022―Mar―31 Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis? Jessy Skaria, Teny M. John, Shibu Varkey, Dimitrios P. Kontoyiannis, Tom Chiller
157 [GO] 2022―Mar―30 The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines Gary McLean, Jeremy Kamil, Benhur Lee, Penny Moore, Thomas F. Schulz, Alexander Muik, et al. (+4)
158 [GO] 2022―Mar―28 Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8 Xin Wu, Tian Xia, Woo-Jin Shin, Kwang-Min Yu, Wooram Jung, Alexandra Herrmann, et al. (+11)
159 [GO] 2022―Mar―17 Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals Thomas Lechmere, Luke B. Snell, Carl Graham, Jeffrey Seow, Zayed A. Shalim, Themoula Charalampous, et al. (+7)
160 [GO] 2022―Mar―15 Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape Nash D. Rochman, Guilhem Faure, Yuri I. Wolf, Peter L. Freddolino, Feng Zhang, Eugene V. Koonin, Michael S. Diamond
161 [GO] 2022―Mar―10 Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quanxin Long, et al. (+11)
162 [GO] 2022―Mar―08 Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein Kyle A. Wolf, Jason C. Kwan, Jeremy P. Kamil, Vinayaka R. Prasad
163 [GO] 2022―Mar―07 Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome Ying Wang, Guojun Wu, Liping Zhao, Weizheng Wang, Vaughn S. Cooper
164 [GO] 2022―Mar―01 Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 + T-Cell Epitopes Identified in COVID-19 Convalescent Individuals Andrew D. Redd, Alessandra Nardin, Hassen Kared, Evan M. Bloch, Brian Abel, Andrew Pekosz, et al. (+5)
165 [GO] 2022―Mar―01 The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters Iart Luca Shytaj, Mohamed Fares, Lara Gallucci, Bojana Lucic, Mahmoud M. Tolba, Liv Zimmermann, et al. (+25)
166 [GO] 2022―Mar―01 Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology Lucía Morales, Juan Carlos Oliveros, Luis Enjuanes, Isabel Sola, Xiang-Jin Meng
167 [GO] 2022―Feb―15 The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics Anubama Rajan, Ashley Morgan Weaver, Gina Marie Aloisio, Joseph Jelinski, Hannah L. Johnson, Susan F. Venable, et al. (+16)
168 [GO] 2022―Feb―15 Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets Jiantao Zhang, Qi Li, Ruth S. Cruz Cosme, Volodymyr Gerzanich, Qiyi Tang, J. Marc Simard, et al. (+2)
169 [GO] 2022―Feb―15 Inhibition of Protein N- Glycosylation Blocks SARS-CoV-2 Infection Aitor Casas-Sanchez, Alessandra Romero-Ramirez, Eleanor Hargreaves, Cameron C. Ellis, Brian I. Grajeda, Igor L. Estevao, et al. (+6)
170 [GO] 2022―Feb―15 SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy Ziwei Yang, Yang Han, Shilei Ding, Wei Shi, Tongqing Zhou, Andrés Finzi, et al. (+4)
171 [GO] 2022―Feb―08 Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages Kofi K. Acheampong, Dylan L. Schaff, Benjamin L. Emert, Jonathan Lake, Sam Reffsin, Emily K. Shea, et al. (+10)
172 [GO] 2022―Feb―08 SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021 Andrew D. Marques, Scott Sherrill-Mix, John K. Everett, Shantan Reddy, Pascha Hokama, Aoife M. Roche, et al. (+33)
173 [GO] 2022―Feb―01 Gasdermin D Inhibits Coronavirus Infection by Promoting the Noncanonical Secretion of Beta Interferon Liyuan Zhao, Liang Li, Mei Xue, Xiang Liu, Chengfan Jiang, Wenzhe Wang, et al. (+4)
174 [GO] 2022―Feb―01 The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release Zhen Yuan, Bing Hu, Hurong Xiao, Xuan Tan, Yan Li, Ke Tang, et al. (+4)
175 [GO] 2022―Feb―01 Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model Shiho Chiba, Maki Kiso, Noriko Nakajima, Shun Iida, Tadashi Maemura, Makoto Kuroda, et al. (+14)
176 [GO] 2022―Jan―25 Great Expectations of COVID-19 Herd Immunity Luca T. Giurgea, David M. Morens, Jacob Yount
177 [GO] 2022―Jan―25 N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition Ruangang Pan, Eveline Kindler, Liu Cao, Yu Zhou, Zhen Zhang, Qianyun Liu, et al. (+10)
178 [GO] 2022―Jan―25 Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2 Joseph W. Golden, Rong Li, Curtis R. Cline, Xiankun Zeng, Eric M. Mucker, Amadeo J. Fuentes-Lao, et al. (+16)
179 [GO] 2022―Jan―25 Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time María M. Gonzalez Lopez Ledesma, Lautaro Sanchez, Diego S. Ojeda, Santiago Oviedo Rouco, Andrés H. Rossi, Augusto Varese, et al. (+51)
180 [GO] 2022―Jan―25 Serological Markers of SARS-CoV-2 Reinfection Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, et al. (+26)
181 [GO] 2022―Jan―18 Vaccinating Children against COVID-19: Commentary and Mathematical Modeling Michael T. Hawkes, Michael F. Good, Melinda M. Pettigrew
182 [GO] 2022―Jan―18 JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis Juhee Son, Shimeng Huang, Qiru Zeng, Traci L. Bricker, James Brett Case, Jinzhu Zhou, et al. (+26)
183 [GO] 2022―Jan―18 Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro , despite Eliciting a Prolonged Antiviral Response Akshamal M. Gamage, Kai Sen Tan, Wharton O. Y. Chan, Zhe Zhang Ryan Lew, Jing Liu, Chee Wah Tan, et al. (+11)
184 [GO] 2022―Jan―11 Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine Wakako Furuyama, Kyle Shifflett, Amanda N. Pinski, Amanda J. Griffin, Friederike Feldmann, Atsushi Okumura, et al. (+10)
185 [GO] 2022―Jan―11 Coronaviruses Nsp5 Antagonizes Porcine Gasdermin D-Mediated Pyroptosis by Cleaving Pore-Forming p30 Fragment Fushan Shi, Qian Lv, Tingjun Wang, Jidong Xu, Wei Xu, Yuhua Shi, et al. (+9)
186 [GO] 2022―Jan―11 Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors Seung Bum Park, Parker Irvin, Zongyi Hu, Mohsin Khan, Xin Hu, Qiru Zeng, et al. (+9)
187 [GO] 2022―Jan―11 Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor Jinliang Wang, Jie Luo, Zhiyuan Wen, Xinxin Wang, Lei Shuai, Gongxun Zhong, et al. (+9)
188 [GO] 2022―Jan―04 Pandemic Influenza Infection Promotes Streptococcus pneumoniae Infiltration, Necrotic Damage, and Proteomic Remodeling in the Heart Maryann P. Platt, Yi-Han Lin, Rosana Wiscovitch-Russo, Yanbao Yu, Norberto Gonzalez-Juarbe, Justin A. Thornton
189 [GO] 2021―Dec―21 Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses Judith M. White, Joshua T. Schiffer, Rachel A. Bender Ignacio, Shuang Xu, Denis Kainov, Aleksandr Ianevski, et al. (+5)
190 [GO] 2021―Dec―07 Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants F. Javier Ibarrondo, Christian Hofmann, Ayub Ali, Paul Ayoub, Donald B. Kohn, Otto O. Yang, et al. (+2)
191 [GO] 2021―Nov―23 Golden Syrian Hamsters as a Model for Revisiting the Role of Biological Sex Differences in SARS-CoV-2 Infection Rafael Tomoya Michita, Indira U. Mysorekar
192 [GO] 2021―Nov―16 A Previously Undiscovered Circular RNA, circTNFAIP3, and Its Role in Coronavirus Replication Liuyang Du, Xingbo Wang, Junli Liu, Jiarong Li, Shengnan Wang, Jing Lei, et al. (+3)
193 [GO] 2021―Nov―16 Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2 Paula Ruiz-Rodriguez, Clara Francés-Gómez, Álvaro Chiner-Oms, Mariana G. López, Santiago Jiménez-Serrano, Irving Cancino-Muñoz, et al. (+15)
194 [GO] 2021―Nov―16 A Bacterial Cell-Based Assay To Study SARS-CoV-2 Protein-Protein Interactions Benjamin L. Springstein, Padraig Deighan, Grzegorz J. Grabe, Ann Hochschild, Jeff F. Miller
195 [GO] 2021―Nov―16 Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, Peter J. Halfmann, Lei Li, Christopher T. Stamper, et al. (+15)
196 [GO] 2021―Nov―09 CCR2 Signaling Restricts SARS-CoV-2 Infection Abigail Vanderheiden, Jeronay Thomas, Allison L. Soung, Meredith E. Davis-Gardner, Katharine Floyd, Fengzhi Jin, et al. (+10)
197 [GO] 2021―Nov―02 Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection Sook-Young Sohn, Janet Hearing, JoAnn Mugavero, Varvara Kirillov, Elena Gorbunova, Luke Helminiak, et al. (+6)
198 [GO] 2021―Nov―02 Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H” Cong Zeng, John P. Evans, Julia N. Faraone, Panke Qu, Yi-Min Zheng, Linda Saif, et al. (+4)
199 [GO] 2021―Oct―26 Identification of ZDHHC17 as a Potential Drug Target for Swine Acute Diarrhea Syndrome Coronavirus Infection Yun Luo, Chee Wah Tan, Shi-Zhe Xie, Ying Chen, Yu-Lin Yao, Kai Zhao, et al. (+7)
200 [GO] 2021―Oct―26 Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach Siaw Shi Boon, Chichao Xia, Maggie Haitian Wang, Ka Lai Yip, Ho Yin Luk, Sile Li, et al. (+6)
201 [GO] 2021―Oct―19 Infectious SARS-CoV-2 Is Emitted in Aerosol Particles Seth A. Hawks, Aaron J. Prussin, Sarah C. Kuchinsky, Jin Pan, Linsey C. Marr, Nisha K. Duggal, John A. Lednicky
202 [GO] 2021―Oct―19 Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks Sriharshita Musunuri, Jonas B. Sandbrink, Joshua Teperowski Monrad, Megan J. Palmer, Gregory D. Koblentz, Paul Keim
203 [GO] 2021―Oct―12 A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases Zhizhen Li, Jianping Wu, Ji Zhou, Baoshi Yuan, Jiqiao Chen, Wanchen Wu, et al. (+14)
204 [GO] 2021―Oct―12 A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19 Tao Chen, Yu-Xin Lin, Yan Zha, Ying Sun, Jinxiu Tian, Zhiying Yang, et al. (+19)
205 [GO] 2021―Oct―12 Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants Linda van Oosten, Jort J. Altenburg, Cyrielle Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, et al. (+24)
206 [GO] 2021―Oct―05 A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants Denise Haslwanter, M. Eugenia Dieterle, Anna Z. Wec, Cecilia M. O’Brien, Mrunal Sakharkar, Catalina Florez, et al. (+25)
207 [GO] 2021―Oct―05 Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H Cong Zeng, John P. Evans, Julia N. Faraone, Panke Qu, Yi-Min Zheng, Linda Saif, et al. (+5)
208 [GO] 2021―Sep―28 Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs Lifeng Fu, Shuai Shao, Yong Feng, Fei Ye, Xue Sun, Qingling Wang, et al. (+10)
209 [GO] 2021―Sep―28 Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages Tadashi Maemura, Makoto Kuroda, Tammy Armbrust, Seiya Yamayoshi, Peter J. Halfmann, Yoshihiro Kawaoka, Stacey Schultz-Cherry
210 [GO] 2021―Sep―28 Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress David Bracquemond, Delphine Muriaux, Francois-Loic Cosset, Vinayaka R. Prasad
211 [GO] 2021―Sep―28 Microbial Ecology and Evolution Are Essential for Understanding Pandemics Megan E. Frederickson, Aspen T. Reese
212 [GO] 2021―Sep―21 SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response Yongzhen Liu, Chao Qin, Youliang Rao, Chau Ngo, Joshua J. Feng, Jun Zhao, et al. (+14)
213 [GO] 2021―Sep―21 Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs Jesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, Alejandro Suárez-Martínez, Luis Ramírez-Martínez, Francisco Quezada-Monroy, et al. (+14)
214 [GO] 2021―Sep―14 MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity Li Wang, Isabel Sola, Luis Enjuanes, Sonia Zuñiga, Adam P. Geballe, Samuel I. Miller
215 [GO] 2021―Sep―14 Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters Wen Su, Sin Fun Sia, Aaron J. Schmitz, Traci L. Bricker, Tyler N. Starr, Allison J. Greaney, et al. (+16)
216 [GO] 2021―Sep―07 Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae Jianghua Wu, Lu Tang, Yanling Ma, Yu Li, Dongmei Zhang, Qian Li, et al. (+4)
217 [GO] 2021―Sep―07 Differential Effects of Prostaglandin D 2 Signaling on Macrophages and Microglia in Murine Coronavirus Encephalomyelitis Abhishek Kumar Verma, Jian Zheng, Matthias Mack, Florent Ginhoux, Stanley Perlman, Diane E. Griffin
218 [GO] 2021―Aug―31 Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee, Stephen P. Goff
219 [GO] 2021―Aug―24 SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity Michihito Sasaki, Shinsuke Toba, Yukari Itakura, Herman M. Chambaro, Mai Kishimoto, Koshiro Tabata, et al. (+9)
220 [GO] 2021―Aug―17 Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome Carter Merenstein, Guanxiang Liang, Samantha A. Whiteside, Ana G. Cobián-Güemes, Madeline S. Merlino, Louis J. Taylor, et al. (+16)
221 [GO] 2021―Aug―17 Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection Minami Nagai, Miyu Moriyama, Takeshi Ichinohe, Diane E. Griffin
222 [GO] 2021―Aug―17 Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 David A. Davis, Haydar Bulut, Prabha Shrestha, Amulya Yaparla, Hannah K. Jaeger, Shin-ichiro Hattori, et al. (+5)
223 [GO] 2021―Aug―10 Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity Abhishek Asthana, Christina Gaughan, Beihua Dong, Susan R. Weiss, Robert H. Silverman, Nancy C. Reich
224 [GO] 2021―Aug―10 Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury Amy C. Sims, Hugh D. Mitchell, Lisa E. Gralinski, Jennifer E. Kyle, Kristin E. Burnum-Johnson, Mariam Lam, et al. (+9)
225 [GO] 2021―Aug―03 The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 Kun Li, David K. Meyerholz, Jennifer A. Bartlett, Paul B. McCray, Matthew B. Frieman, Diane E. Griffin
226 [GO] 2021―Aug―03 Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains Enya Qing, Tom Kicmal, Binod Kumar, Grant M. Hawkins, Emily Timm, Stanley Perlman, et al. (+2)
227 [GO] 2021―Aug―02 Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic? Arturo Casadevall, Susan R. Weiss, Michael J. Imperiale
228 [GO] 2021―Jul―27 Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner Fatima Amanat, Shirin Strohmeier, Wen-Hsin Lee, Sandhya Bangaru, Andrew B. Ward, Lynda Coughlan, et al. (+2)
229 [GO] 2021―Jul―27 Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques Kim J. Hasenkrug, Friederike Feldmann, Lara Myers, Mario L. Santiago, Kejun Guo, Bradley S. Barrett, et al. (+19)
230 [GO] 2021―Jul―27 D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Sheng-Han Wang, Han-Chieh Kao, Ya-Min Tsai, et al. (+7)
231 [GO] 2021―Jul―27 B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau, Takuya Tada, Vincent R. Racaniello
232 [GO] 2021―Jul―20 Tackling Antimicrobial Resistance in the Shadow of COVID-19 Ami Patel
233 [GO] 2021―Jul―20 Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations Jobin John Jacob, Karthick Vasudevan, Agila Kumari Pragasam, Karthik Gunasekaran, Balaji Veeraraghavan, Ankur Mutreja, et al. (+2)
234 [GO] 2021―Jul―13 Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model Santosh Dhakal, Camilo A. Ruiz-Bedoya, Ruifeng Zhou, Patrick S. Creisher, Jason S. Villano, Kirsten Littlefield, et al. (+25)
235 [GO] 2021―Jul―06 Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication Xueyan Zhang, Haojie Hao, Li Ma, Yecheng Zhang, Xiao Hu, Zhen Chen, et al. (+5)
236 [GO] 2021―Jul―06 Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium Franck Touret, Léa Luciani, Cécile Baronti, Maxime Cochin, Jean-Sélim Driouich, Magali Gilles, et al. (+4)
237 [GO] 2021―Jun―29 Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients Jennifer M. Sasson, Joseph J. Campo, Rebecca M. Carpenter, Mary K. Young, Arlo Z. Randall, Krista Trappl-Kimmons, et al. (+10)
238 [GO] 2021―Jun―29 Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects Lynda Rocheleau, Geneviève Laroche, Kathy Fu, Corina M. Stewart, Abdulhamid O. Mohamud, Marceline Côté, et al. (+4)
239 [GO] 2021―Jun―22 Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides Bing Wang, Vladimir Svetlov, Yuri I. Wolf, Eugene V. Koonin, Evgeny Nudler, Irina Artsimovitch, Richard Gerald Brennan
240 [GO] 2021―Jun―11 Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes Takuya Tada, Belinda M. Dcosta, Marie I. Samanovic, Ramin S. Herati, Amber Cornelius, Hao Zhou, et al. (+5)
241 [GO] 2021―May―10 The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia Wei Zou, Min Xiong, Siyuan Hao, Elizabeth Yan Zhang, Nathalie Baumlin, Michael D. Kim, et al. (+4)
242 [GO] 2021―May―10 An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines Yan Guo, Wenhui He, Huihui Mou, Lizhou Zhang, Jing Chang, Shoujiao Peng, et al. (+10)
243 [GO] 2021―May―10 Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics Meiling Dai, Wenjuan Du, Carles Martínez-Romero, Tim Leenders, Tom Wennekes, Guus F. Rimmelzwaan, et al. (+6)
244 [GO] 2021―May―03 Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, Lai Xu, Shima Shahbaz, Wendy Sligl, et al. (+6)
245 [GO] 2021―Apr―26 Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment Jia Liu, Xuecheng Yang, Hua Wang, Ziwei Li, Hui Deng, Jing Liu, et al. (+21)
246 [GO] 2021―Apr―26 ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia W. Posch, J. Vosper, V. Zaderer, A. Noureen, S. Constant, R. Bellmann-Weiler, et al. (+3)
247 [GO] 2021―Apr―19 COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions Opeyemi S. Adeniji, Leila B. Giron, Mansi Purwar, Netanel F. Zilberstein, Abhijeet J. Kulkarni, Maliha W. Shaikh, et al. (+11)
248 [GO] 2021―Apr―19 Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, Shiwei Xu, Joshua A. Weiner, Evan M. Bloch, et al. (+17)
249 [GO] 2021―Apr―19 Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice Xiang Liu, Ali Zaid, Joseph R. Freitas, Nigel A. McMillan, Suresh Mahalingam, Adam Taylor, Diane E. Griffin
250 [GO] 2021―Apr―12 SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98 Amin Addetia, Nicole A. P. Lieberman, Quynh Phung, Tien-Ying Hsiang, Hong Xie, Pavitra Roychoudhury, et al. (+8)
251 [GO] 2021―Apr―05 Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions Christopher J. Day, Benjamin Bailly, Patrice Guillon, Larissa Dirr, Freda E.-C. Jen, Belinda L. Spillings, et al. (+6)
252 [GO] 2021―Mar―27 Dynamic Dissection of the Endocytosis of Porcine Epidemic Diarrhea Coronavirus Cooperatively Mediated by Clathrin and Caveolae as Visualized by Single-Virus Tracking Yangyang Li, Jian Wang, Wei Hou, Yanke Shan, Shouyu Wang, Fei Liu, Anne Moscona
253 [GO] 2021―Mar―15 Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication Lily E. Adams, Kenneth H. Dinnon, Yixuan J. Hou, Timothy P. Sheahan, Mark T. Heise, Ralph S. Baric, Diane E. Griffin
254 [GO] 2021―Mar―08 The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 Arturo Casadevall, Liise-anne Pirofski, Michael J. Joyner, Danielle A. Garsin
255 [GO] 2021―Mar―01 Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection Javier Gutiérrez-Álvarez, José M. Honrubia, Raúl Fernández-Delgado, Li Wang, Carlos Castaño-Rodríguez, Sonia Zúñiga, et al. (+3)
256 [GO] 2021―Mar―01 Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets Young-Il Kim, Dokyun Kim, Kwang-Min Yu, Hogyu David Seo, Shin-Ae Lee, Mark Anthony B. Casel, et al. (+7)
257 [GO] 2021―Mar―01 Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, Michael Schotsaert, Lynda Coughlan, Adolfo García-Sastre, et al. (+2)
258 [GO] 2021―Feb―15 The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients? Nicole de Buhr, Maren von Köckritz-Blickwede, Scot P. Ouellette
259 [GO] 2021―Feb―15 Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Chuan Tien Hung, Satoshi Ikegame, Joshua A. Acklin, Shreyas S. Kowdle, et al. (+26)
260 [GO] 2021―Feb―08 Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19 Ryan M. Pace, Janet E. Williams, Kirsi M. Järvinen, Mandy B. Belfort, Christina D. W. Pace, Kimberly A. Lackey, et al. (+16)
261 [GO] 2021―Feb―08 Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis Wern Hann Ng, Thomas Tipih, Nigel A. Makoah, Jan-G Vermeulen, Dominique Goedhals, Joseph B. Sempa, et al. (+4)
262 [GO] 2021―Feb―01 Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection” Jeffrey E. Gold, David J. Hurley, Balázs Rada, William H. Baumgartl, Larry P. Tilley, Warren E. Licht, Liise-anne Pirofski
263 [GO] 2021―Feb―01 MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection Ekaterina Marakasova, Ancha Baranova, Liise-anne Pirofski
264 [GO] 2021―Jan―18 Coronaviruses Associated with the Superfamily Musteloidea Alison E. Stout, Qinghua Guo, Jean K. Millet, Ricardo de Matos, Gary R. Whittaker, Vinayaka R. Prasad
265 [GO] 2021―Jan―18 Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro Nathan E. Stone, Sierra A. Jaramillo, Ashley N. Jones, Adam J. Vazquez, Madison Martz, Lora M. Versluis, et al. (+12)
266 [GO] 2021―Jan―18 SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia John Everett, Pascha Hokama, Aoife M. Roche, Shantan Reddy, Young Hwang, Lyanna Kessler, et al. (+13)
267 [GO] 2021―Jan―18 SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike Jenna J. Guthmiller, Olivia Stovicek, Jiaolong Wang, Siriruk Changrob, Lei Li, Peter Halfmann, et al. (+20)
268 [GO] 2021―Jan―18 Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors Yuewen Luo, Fei Yu, Mo Zhou, Yang Liu, Baijin Xia, Xiantao Zhang, et al. (+11)
269 [GO] 2021―Jan―18 Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants Alexander Crits-Christoph, Rose S. Kantor, Matthew R. Olm, Oscar N. Whitney, Basem Al-Shayeb, Yue Clare Lou, et al. (+14)
270 [GO] 2021―Jan―18 Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion Russell Y. Neches, Nikos C. Kyrpides, Christos A. Ouzounis, Diane E. Griffin
271 [GO] 2021―Jan―11 Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? Heenam Stanley Kim, Maria Gloria Dominguez Bello
272 [GO] 2021―Jan―11 Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV Marta C. Nunes, Clare L. Cutland, Keith P. Klugman, Shabir A. Madhi, Julian Parkhill
273 [GO] 2020―Dec―21 Designing the Next Generation of Vaccines: Relevance for Future Pandemics Jorge Domínguez-Andrés, Reinout van Crevel, Maziar Divangahi, Mihai G. Netea, Vinayaka R. Prasad
274 [GO] 2020―Dec―14 Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro Francesca Curreli, Sofia M. B. Victor, Shahad Ahmed, Aleksandra Drelich, Xiaohe Tong, Chien-Te K. Tseng, et al. (+3)
275 [GO] 2020―Dec―14 Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses Jonas Nascimento Conde, William R. Schutt, Elena E. Gorbunova, Erich R. Mackow, John T. Patton
276 [GO] 2020―Nov―23 Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients Heba H. Mostafa, John A. Fissel, Brian Fanelli, Yehudit Bergman, Victoria Gniazdowski, Manoj Dadlani, et al. (+5)
277 [GO] 2020―Nov―23 Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients Jeffrey E. Gold, William H. Baumgartl, Ramazan A. Okyay, Warren E. Licht, Paul L. Fidel, Mairi C. Noverr, et al. (+5)
278 [GO] 2020―Nov―23 After COVID-19 We Will Need a New Research System. We Need To Start Planning Now Stefano Bertuzzi, Victor J. DiRita
279 [GO] 2020―Nov―16 Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2 Maitrayee Chatterjee, Jos P. M. van Putten, Karin Strijbis, Danielle A. Garsin
280 [GO] 2020―Nov―09 Erratum for Westmeier et al., “Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients” Jaana Westmeier, Krystallenia Paniskaki, Zehra Karaköse, Tanja Werner, Kathrin Sutter, Sebastian Dolff, et al. (+14)
281 [GO] 2020―Nov―09 Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium Siyuan Hao, Kang Ning, Cagla Aksu Kuz, Kai Vorhies, Ziying Yan, Jianming Qiu, Xiang-Jin Meng
282 [GO] 2020―Nov―02 Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses P. Simmonds, Diane E. Griffin
283 [GO] 2020―Nov―02 Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area S. Wesley Long, Randall J. Olsen, Paul A. Christensen, David W. Bernard, James J. Davis, Maulik Shukla, et al. (+20)
284 [GO] 2020―Oct―26 The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic Michael F. Good, Michael T. Hawkes, Alan Sher
285 [GO] 2020―Oct―19 Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein Xiaohui Wang, Joy-Yan Lam, Wan-Man Wong, Chun-Kit Yuen, Jian-Piao Cai, Shannon Wing-Ngor Au, et al. (+5)
286 [GO] 2020―Oct―19 Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain Victor K. Outlaw, Francesca T. Bovier, Megan C. Mears, Maria N. Cajimat, Yun Zhu, Michelle J. Lin, et al. (+11)
287 [GO] 2020―Oct―19 SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans Rayhane Nchioua, Dorota Kmiec, Janis A. Müller, Carina Conzelmann, Rüdiger Groß, Chad M. Swanson, et al. (+8)
288 [GO] 2020―Oct―19 Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals Guillaume Beaudoin-Bussières, Annemarie Laumaea, Sai Priya Anand, Jérémie Prévost, Romain Gasser, Guillaume Goyette, et al. (+15)
289 [GO] 2020―Oct―12 From People to Panthera: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo Denise McAloose, Melissa Laverack, Leyi Wang, Mary Lea Killian, Leonardo C. Caserta, Fangfeng Yuan, et al. (+32)
290 [GO] 2020―Oct―12 Pandemic Legion History More Complex than Previously Thought Jean-Nicolas Tournier, Vinayaka R. Prasad
291 [GO] 2020―Sep―28 Antiviral Drug Discovery To Address the COVID-19 Pandemic Douglas D. Richman, Michael S. Diamond
292 [GO] 2020―Sep―28 Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome Chengjin Ye, Kevin Chiem, Jun-Gyu Park, Fatai Oladunni, Roy Nelson Platt, Tim Anderson, et al. (+4)
293 [GO] 2020―Sep―28 S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit Phuong Nguyen-Contant, A. Karim Embong, Preshetha Kanagaiah, Francisco A. Chaves, Hongmei Yang, Angela R. Branche, et al. (+4)
294 [GO] 2020―Sep―28 SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures Amir Barzin, John L. Schmitz, Samuel Rosin, Rameet Sirpal, Martha Almond, Carole Robinette, et al. (+21)
295 [GO] 2020―Sep―21 Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients Jaana Westmeier, Krystallenia Paniskaki, Zehra Karaköse, Tanja Werner, Kathrin Sutter, Sebastian Dolff, et al. (+15)
296 [GO] 2020―Sep―21 Measles-Mumps-Rubella Vaccine and COVID-19 Relationship Öner Özdemir, Richard E. Lloyd, Michael S. Gilmore
297 [GO] 2020―Sep―21 Reply to Özdemir, “Measles-Mumps-Rubella Vaccine and COVID-19 Relationship” Paul L. Fidel, Mairi C. Noverr, Michael S. Gilmore
298 [GO] 2020―Sep―14 Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2 Idoia Busnadiego, Sonja Fernbach, Marie O. Pohl, Umut Karakus, Michael Huber, Alexandra Trkola, et al. (+3)
299 [GO] 2020―Sep―07 An Early Pandemic Analysis of SARS-CoV-2 Population Structure and Dynamics in Arizona Jason T. Ladner, Brendan B. Larsen, Jolene R. Bowers, Crystal M. Hepp, Evan Bolyen, Megan Folkerts, et al. (+18)
300 [GO] 2020―Aug―24 GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection Shin-ichiro Hattori, Nobuyo Higshi-Kuwata, Jakka Raghavaiah, Debananda Das, Haydar Bulut, David A. Davis, et al. (+11)
301 [GO] 2020―Aug―10 The Unrecognized Threat of Secondary Bacterial Infections with COVID-19 Mylene Vaillancourt, Peter Jorth
302 [GO] 2020―Aug―10 Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic Michael J. Imperiale, Arturo Casadevall
303 [GO] 2020―Jul―27 Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations? J. C. Onishi, M. M. Häggblom, S. A. Shapses, Dominique Soldati-Favre
304 [GO] 2020―Jul―20 Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2 Yvonne C. F. Su, Danielle E. Anderson, Barnaby E. Young, Martin Linster, Feng Zhu, Jayanthi Jayakumar, et al. (+20)
305 [GO] 2020―Jul―06 Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework Liise-anne Pirofski, Arturo Casadevall, Thomas E. Morrison, Danielle A. Garsin
306 [GO] 2020―Jun―22 Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection? Paul L. Fidel, Mairi C. Noverr, Michael S. Gilmore
307 [GO] 2020―Jun―01 Pandemic COVID-19 Joins History’s Pandemic Legion David M. Morens, Peter Daszak, Howard Markel, Jeffery K. Taubenberger, Benhur Lee, Vinayaka R. Prasad
308 [GO] 2020―Jun―01 Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses Yongjun Tan, Theresa Schneider, Matthew Leong, L. Aravind, Dapeng Zhang, Igor B. Zhulin
309 [GO] 2020―May―25 COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure Eftychios Siniorakis, Spyridon Arvanitakis, Ioannis Nikolopoulos, Maximilianos Elkouris, Arturo Casadevall
310 [GO] 2020―May―25 Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets Su-Jin Park, Kwang-Min Yu, Young-Il Kim, Se-Mi Kim, Eun-Ha Kim, Seong-Gyu Kim, et al. (+14)
311 [GO] 2020―Apr―06 Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection Kun Li, Zhuo Li, Christine Wohlford-Lenane, David K. Meyerholz, Rudragouda Channappanavar, Dong An, et al. (+4)
312 [GO] 2020―Mar―30 Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19 Robin Patel, Esther Babady, Elitza S. Theel, Gregory A. Storch, Benjamin A. Pinsky, Kirsten St. George, et al. (+2)
313 [GO] 2020―Mar―23 Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection David S. Fedson, Steven M. Opal, Ole Martin Rordam
314 [GO] 2020―Feb―10 Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection Enya Qing, Michael Hantak, Stanley Perlman, Tom Gallagher, Mark R. Denison
 [1] 

314 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec